References
  1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Archives of internal medicine. 2004 Jun 28;164(12):1275-84
  2. Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD, Rodriguez- Rodriguez A, Cardenas- Roldan J, Pineda-Tamayo R, et al. Sjogren’s syndrome at the crossroad of polyautoimmunity. J Autoimmun. 2012; 39:199-205.
  3. Acs M, Caffery B, Barnett M, Edmonds C, Johnson-Tong L, Maharaj R, Pemberton B, Papinski D, Harthan J, Srinivasan S. Customary practices in the monitoring of dry eye disease in Sjogren’s syndrome. Journal of optometry. 2018 Oct 1;11(4):232-41.
  4. Zhu JW, Wang JY. Eyelid swelling and primary Sjögren’s syndrome. N Engl J Med. 2013 Jun 27;368:2501
  5. Akpek EK, Bunya VY, Saldanha IJ. Sjögren’s syndrome: more than just dry eye. Cornea. 2019 May;38(5):658.
  6. Hartert M, Melcher B, Huertgen M. Association of early-onset myasthenia gravis and primary Sjögren’s syndrome: a case-based narrative review. Clinical Rheumatology. 2022 Aug 1:1-7.
  1. Sidén Å, Lindahl G. Signs of Sjögren’s syndrome in a patient with myasthenia gravis. Acta neurologica scandinavica. 1990 Feb;81(2):179-80.
  2. Fujiu K, Kanno R, Shio Y, Ohsugi J, Nozawa Y, Gotoh M. Triad of thymoma, myasthenia gravis and pure red cell aplasia combined with Sjögren’s syndrome. The Japanese Journal of Thoracic and Cardiovascular Surgery. 2004 Jul;52(7):345-8.
  3. Rousseff RT. Diagnosis of myasthenia gravis. Journal of clinical medicine. 2021 Apr 16;10(8):1736.
  4. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscular Disorders. 2006 Jul 1;16(7):459-67.
  5. Robinson MA, Nagurla SR, Noblitt TR, Almaghlouth NK, Al-Rahamneh MM, Cashin LM. Falsely positive fourth generation ADVIA Centaur® HIV Antigen/Antibody Combo assay in the presence of autoimmune hepatitis type I (AIH). IDCases. 2020 Jan 1;21:e00886.
  6. Dasgupta, A., Banerjee, S.K. and Datta, P., 1999. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum: elimination of this interference by using polyclonal antisera against rheumatoid factors. American journal of clinical pathology , 112 (6), pp.753-756
  7. Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best practice & research Clinical endocrinology & metabolism. 2013 Oct 1;27(5):647-61.
  8. Cole LA, Rinne KM, Shahabi S, Omrani A. False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clinical chemistry. 1999 Feb 1;45(2):313-4.
  9. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 ACR-EULAR classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis & rheumatology (Hoboken, NJ). 2017 Jan;69(1):35.
  10. Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjögren’s syndrome: underlying immunological mechanisms, clinical presentation, and management. Frontiers in Immunology. 2019 Jun 12;10:1327.
  11. Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, Gandia M, Akasbi M, Siso A, Ballester E, Torres A. Bronchiectasis in primary Sjögren’s syndrome: prevalence and clinical significance. Clinical & Experimental Rheumatology. 2010 Sep 1;28(5):647.